Oncolines Technology Platforms for Precision Oncology
Cell-Based Assays to Determine Genetic Drivers and Biological Pathways for Precision Oncology
Available on a fee-for-service basis and collaborations via an integrated precision medicine approach.
It is our mission to bring improved and novel therapies to the right patient population faster.